A new diagnostic test developed from research at the Universities of Cambridge and Dundee has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
In this piece for The Conversation, Carlos López-Gómez from Cambridge's Institute for Manufacturing, discusses the role that small and medium-sized businesses might play in a post-Brexit economy.
Tony Kouzarides is passionate about ecosystems: well-balanced communities that flourish on mutual and dynamic interactions. But the ecosystems that excite him are not made up of plants, animals and environments. They’re made up of experts.
Nanotechnology is creating new opportunities for fighting disease – from delivering drugs in smart packaging to nanobots powered by the world’s tiniest engines.
The stirrings of a revolution are starting to ripple through hundreds of laboratories. It’s a revolution that aims to result in new medicines – faster and with fewer failures – and it’s being led by three UK universities and three global pharmaceutical companies.
Cambridge-based start-up company Bicycle Therapeutics has recently raised £40 million from a range of investors to bring its cancer drug candidates to clinical trials.
Is the knowledge and scholarship that universities produce relevant to the problems the world faces? In a new essay co-authored with an international group of researchers, Dr Bhaskar Vira of the University of Cambridge Conservation Research Institute (UCCRI) and the Department of Geography argues that in order for science to best serve society and the planet, universities and researchers need to adjust their focus and take responsibility for institutional innovation in five key areas.
Are strict IP policies harming the development of sustainable technologies? In this article for The Conversation, Frank Tietze from the Institute for Manufacturing investigates how the open source approach taken by companies such as Tesla may help the economy and the planet.
A University of Cambridge spin-out company has raised £7 million in new funding, which will help in the development of treatments for liver and lung disease.
With inequalities set to get worse, it’s time to take radical action, says Jaideep Prabhu, Director of Centre for India & Global Business, Cambridge Judge Business School, writing for The Conversation. Could the answer lie in the ‘frugal revolution’ that is already under way?